Log in to your Inderes Free account to see all free content on this page.

PharmaLundensis

0.10 SEK

+27.46%

Less than 1K followers

PHAL

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+27.46 %
-58.27 %
-60.19 %
-57.93 %
-79.13 %
-81.91 %
-81.90 %
-87.40 %
-96.84 %

PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.

Read more
Market cap
6.65M SEK
Turnover
13.74K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21.5.
2026

Interim report Q1'26

20.8.
2026

Interim report Q2'26

19.11.
2026

Interim report Q3'26